EUR 4.9
(1.07%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 14.35 Million EUR | 10.03% |
2022 | 13.04 Million EUR | 12.86% |
2021 | 11.56 Million EUR | 0.0% |
2020 | - EUR | 0.0% |
2019 | - EUR | 0.0% |
2018 | - EUR | 0.0% |
2017 | - EUR | -100.0% |
2016 | 1.00 EUR | -99.99% |
2015 | 11 Thousand EUR | -21.43% |
2014 | 14 Thousand EUR | 7.69% |
2013 | 13 Thousand EUR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2023 Q2 | 14.01 Million EUR | 7.36% |
2023 Q4 | 14.35 Million EUR | 2.48% |
2023 FY | 14.35 Million EUR | 10.03% |
2022 Q4 | 13.04 Million EUR | 4.11% |
2022 Q2 | 12.53 Million EUR | 0.0% |
2021 Q2 | - EUR | 0.0% |
2021 Q4 | - EUR | 0.0% |
2020 Q4 | - EUR | 0.0% |
2020 Q2 | - EUR | 0.0% |
2019 Q2 | - EUR | 0.0% |
2019 Q4 | - EUR | 0.0% |
2018 Q2 | - EUR | 0.0% |
2018 Q4 | - EUR | 0.0% |
2017 Q4 | - EUR | 0.0% |
2017 Q2 | - EUR | -100.0% |
2016 Q2 | 11 Thousand EUR | 0.0% |
2016 Q4 | 1.00 EUR | -99.99% |
2015 Q4 | 11 Thousand EUR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Nicox S.A. | - EUR | -Infinity% |
FERMENTALG | 6.8 Million EUR | -110.961% |
argenx SE | 281.12 Million EUR | 94.893% |
BioSenic S.A. | - EUR | -Infinity% |
Celyad Oncology SA | 1.26 Million EUR | -1039.524% |
Hyloris Pharmaceuticals SA | 1.00 EUR | -1435799900.0% |
Onward Medical N.V. | 936 Thousand EUR | -1433.974% |
Oxurion NV | 128 Thousand EUR | -11117.188% |
PHAXIAM Therapeutics S.A. | 671 Thousand EUR | -2039.791% |
Financière de Tubize SA | - EUR | -Infinity% |
UCB SA | 1.03 Billion EUR | 98.607% |